Valerian for Conscious Sedation in Patients Submitted to Impacted Lower Third Molars Surgery

Blood Pressure Clinical Trial

Official title: Valeriana Officinalis L. for Conscious Sedation in Patients Submitted to Impacted Lower Third Molars Surgery: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

Status Completed

Clinical Trial Summary

The aim of the present study was to evaluate the efficacy of Valeriana officinalis L. 100 mg in single oral doses one hour preoperative as conscious sedation during the impacted lower third molar surgery.

Clinical Trial Description

Evaluate the efficacy of Valeriana officinalis L. (Valerian) for control of anxiety during third molar surgery. Study design: A single oral dose of either valerian (100 mg) or placebo was randomly administered one hour before each surgical procedure to 20 volunteers between 17 and 31 years of age. Anxiety level was assessed through questionnaires, physiological parameters (blood pressure and heart rate) and the observation of signs. ;

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Blood Pressure
• Dental Anxiety
• Heart Rate

• NCT number: NCT01612130
• Study type: Interventional
• Source: Federal University of the Valleys of Jequitinhonha and Mucuri
• Status: Completed
• Phase: N/A
• Start date: March 2003
• Completion date: August 2003